Organization Overview
Alternative names
acalabrutinib (calquence) (1 trial)
acetylcysteine (mucomyst) (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
capecitabine (xeloda) (1 trial)
carboplatin (paraplatin) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
cytarabine (cytosar-u) (4 trials)
fludeoxyglucose f-18 (1 trial)
fluorouracil (efudex) (3 trials)
gemcitabine (gemzar) (1 trial)
allogeneic adipose derived mesenchymal stem cell (1 trial)
allogeneic natural killer cells (1 trial)
azacitidine (vidaza) (3 trials)
bendamustine (treanda) (1 trial)
cabozantinib (cometriq) (1 trial)
docetaxel (taxotere) (1 trial)
fab-fragment of anti-human cd4 (1 trial)
fluvastatin (lescol) (1 trial)
glofitamab (Columvi) (1 trial)
Acute Kidney Injury (Phase 4)
Adenocarcinoma (Phase 2)
Aortic Valve Stenosis (Phase 2)
Arthritis (Phase 2)
Arthritis, Psoriatic (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Astrocytoma (Phase 3)
Autoimmune Diseases (Phase 2)
Bipolar Disorder (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Squamous Cell (Phase 3)
Cardiomyopathies (Phase 4)
Carotid Stenosis (Phase 2)
Constriction, Pathologic (Phase 2)
Coronary Artery Disease (Phase 2)
Coronary Disease (Phase 4)
Diabetic Nephropathies (Phase 3)
Diabetic Retinopathy (Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 3)
Glucose Intolerance (Phase 4)
Glucose Metabolism Disorders (Phase 4)
Heart Diseases (Phase 4)
Heart Failure (Phase 2)
Hypertension (Phase 4)
Hypolipoproteinemias (Phase 4)
Infarction (Phase 3)
Inflammation (Phase 2)
Ischemia (Phase 2)
Kidney Diseases (Phase 3)
Laryngeal Diseases (Phase 2)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Lymphoma (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Macular Edema (Phase 3)
Metabolic Diseases (Phase 4)
Mucositis (Phase 3)
Multiple Myeloma (Phase 3)
Myocardial Infarction (Phase 3)
Myocardial Reperfusion Injury (Phase 4)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 3)
Oligodendroglioma (Phase 3)
Prediabetic State (Phase 4)
Premature Birth (Phase 4)
Recurrence (Phase 2)
Reperfusion Injury (Phase 4)
Retinal Diseases (Phase 3)
Retinal Vein Occlusion (Phase 3)
Rheumatic Diseases (Phase 2)
Sepsis (Phase 3)
Shock (Phase 3)
Shock, Septic (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
ST Elevation Myocardial Infarction (Phase 3)
Stomach Neoplasms (Phase 3)
Stomatitis (Phase 3)
Toxemia (Phase 3)
Ventricular Premature Complexes (Phase 4)